Cancer Research Communications
@CRC_AACR
Follow Cancer Research Communications, an open access journal, covering the full spectrum of cancer science and medicine. Published by @AACR.
Keep up with the latest published articles in Cancer Research Communications. Sign up for alerts delivered straight to your inbox! bit.ly/3XaqQti
Recently published: #GlycemicControl and #ProstateCancer Mortality Risk in Veterans with Type 2 #Diabetes Mellitus, by Kinfe G. Bishu et al. doi.org/10.1158/2767-9… @ProfMulugeta @MUSC_COM #OpenAccess
Stay up to date with the latest research on Emerging Technologies and Data Science published in Cancer Research Communications. brnw.ch/21wUqy6
Recently published: Metastatic #CervicalCancer in the Asia-Pacific Region: Current Treatment Landscape and Barriers, by Jeffrey Chee-Hong Goh et al. doi.org/10.1158/2767-9… @JeffreyCGoh1 #AsiaPacificRegion #OpenAccess
Recently published: Defining the #OvarianCancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by #ExtracellularVesicles, by Jared Sipes et al. doi.org/10.1158/2767-9… @JBurdetteLab @KUPathology #OpenAccess
ICYMI: #HDACi Target #DNAReplication Regulators and #ReplicationStress in #EwingSarcoma Cells. This study adds important data to the field on the Ewing sarcoma epigenome, particularly targetable vulnerabilities that may be exploitable in the clinic. doi.org/10.1158/2767-9…
Stay up to date with the latest research on Molecular and Cellular Biology published in Cancer Research Communications. brnw.ch/21wUmEN
ICYMI: High-Throughput Drug Screening of #ClearCellOvarianCancer Organoids Reveals Vulnerability to #ProteasomeInhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target. doi.org/10.1158/2767-9… #UnfoldedProteinResponse #OpenAccess
Recently published: In Situ Pro-Inflammatory Effects of Dazostinag Alone or With Chemotherapy Upon the #TumorMicroenvironment of Patients With #HeadandNeckSquamousCellCarcinoma, by Richard C. Gregory et al. doi.org/10.1158/2767-9… #HNSCC #OpenAccess
Recently published: Assessing #MC1R Variants in #LentigoMaligna #Melanoma Within the Utah Population, by Amanda Jiang et al. doi.org/10.1158/2767-9… @amandaajiang @UofUMedicine @huntsmancancer #OpenAccess
Stay up to date with the latest on Clinical Research and Trials published in Cancer Research Communications. brnw.ch/21wUj1o
Tumor-Specific S1P Targeting Using an #Acrolein-Based DDS —don't miss this rigorous preclinical study of a prodrug allowing tumor-specific S1P targeting, which avoids established side effects of systemic S1P targeting. doi.org/10.1158/2767-9… #OpenAccess
Recently published: Epidemiological Features and Age-related Differences in Management among Patients with #GastrointestinalStromalTumors in Japan: A National Cancer Registry Study, by Hidekazu Hirano et al. doi.org/10.1158/2767-9… #OpenAccess
Stay up to date with the latest research on Precision Medicine and Biomarkers published in Cancer Research Communications. brnw.ch/21wUdHZ
ICYMI: #Cisplatin-Induced APE2 Overexpression Disrupts MYH9 Function and Causes Hearing Loss. This study demonstrates how cisplatin induces APE2-dependent ototoxicity, emphasizing the promise of targeting APE2 for preventing cisplatin-induced hearing loss. brnw.ch/21wUc7R
ICYMI: #P4HA1 Mediates #Hypoxia-Induced Invasion in Human #PancreaticCancer Organoids. The authors demonstrate that hypoxia increases invasion across a cohort of human #PDAC organoids, identifying P4HA1 as a driver of hypoxia-enhanced invasion. brnw.ch/21wUatw #OpenAccess
Stay up to date with the latest on Therapeutic Research and Development published in Cancer Research Communications. brnw.ch/21wUa7K
Recently published: Plasma Cell-Free #HPV DNA and Oral Gargle HPV DNA in Patients with HPV-related #OropharyngealCancer Treated with #Radiotherapy, by Michelle Echevarria et al. doi.org/10.1158/2767-9… @rprobinpark @JJCaudell @AmelioLab @MoffittNews #OpenAccess
Stay up to date with Cancer Research Communications by signing up for eTOC alerts. brnw.ch/21wU8Gi
ICYMI: Microbiome & ICIs: A SCRUM-Japan MONSTAR-SCREEN Study. The authors' findings highlight the potential clinical impact of microbiome variations on cancer treatment outcomes, providing insights for future studies aimed at overcoming ICI resistance. brnw.ch/21wU8jq
Recently published: #Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-expressing #NonSmallCellLungCancer, by Tae Hata et al. doi.org/10.1158/2767-9… #NSCLC #PDL1 #OpenAccess
